As of September 2021, around ** percent of business that closed temporarily due to the COVID-19 pandemic in the United States have reopened. Businesses in the beauty services industries showed the best recovery with ** percent of their previously closed business locations reopened by September 2021.

Project Overview This dataset comprises 5,223 unique documents published online on the official websites of governors’ or health departments’ offices across all U.S. states in relation to the COVID-19 vaccination program. The dataset covers the timeframe from December 2020, when states began preparing for Phase 1a of the COVID-19 vaccination allocation program, to September 2021, when COVID-19 vaccines were widely available to all adults and frequently mandated. It is a collaborative effort between the Yale School of Medicine and Yale's Tobin Center for Economic Policy. Our aim is to archive publications from State Governors and Departments of Health across 50 U.S. states and the District of Columbia, which researchers can utilize to assess the efficacy of communication strategies employed during this period. Ultimately, we aim to support policymakers in making more informed decisions. Data and Data Collection Overview This collection comprises 5,223 unique publications from the governors’ office and the State Department of Health from 50 states and the District of Columbia, released during the period from December 1, 2020 to September 30, 2021, and collected by the research team (specifically AM) between September 2021 and July 2024. Data were collected from the respective states’ Governor’s and Department of Health websites, using search with a custom data range, in week-long increments (e.g., 12/01/2020-12/07/2020), and key words . Search results were reviewed to satisfy the following inclusion/exclusion criteria: Inclusion criteria: Publications from state-run websites ending in .gov that relate to the COVID-19 vaccination program (except New Mexico’s Department of Health which ends in .org and Minnesota’s Department of Health which ends in .us). Exclusion criteria: Publications from county-level organizations, universities, and other organizations not related to state government branches or health sectors (e.g., .org, .com); videos with no transcription posted by the source; publications with no text; publications that refer to other than COVID-19 vaccines; publications not in the English language. The included publications are organized by sources → month → week of the publication. Next, the publications were organized by the publication type (classification done by BV, FFB, PW, LVDM, AG, and AM): information from the Governor and other state officials, policy from the Governor or other state officials, information from the State Department of Health or other state health officials, policy from the State Department of Health or other state health officials, flyers (1-2 pages with primarily visual information), and milestones (publications of quantitative patterns in the form of tables or graphs only). AM and HP conducted the final quality control. The number of publications from each state’s officials, by type and by month from December 2020 to September 2021 are also listed as documentation (see file named Number_of_publications_by_state_by_month_December_2020_September_2021.csv). Selection and Organization of Shared Data The top-level-organization of all 10,446 primary files is by state, using conventional two-letter acronyms. Additionally, each item is classified both by time of publication (in folders labeled “raw”) and by type (in folders with self-explanatory labels, “Policy”, “Flyer”, “Info” and “Milestones”). Thus, each unique item appears more than once in the full deposit. A full inventory of the items is also shared in both Excel and CSV formats, containing a full list of publications with their upload dates, as well as the number of publications by state and by type, organized by month from December 2020 to September 2021. Additionally, the documentation includes this Data Narrative and an administrative README file.

Abstract

The COVID-19 Socioeconomic-/Cash-Based Intervention Post-Distribution Monitoring (CBI PDM) was conducted in September 2021 to assess the needs of the refugees in Eastern Nepal and Kathmandu. The survey consists of two parts. The first part of the survey measures the impact of COVID-19 on refugees' knowledge, behavior and health as well as refugees' economic livelihoods and the second part monitors the latest cash assistance programme. As a response to COVID-19, UNHCR has since the start of the pandemic launched multiple new cash grants and expanded existing programs. UNHCR's cash assistance complements governments' efforts by contributing with an additional safety net for vulnerable refugees and others left behind. Also during the course of 2021, UNHCR has continued to support the COVID-19 emergency response with cash assistance. UNHCR uses PDM as a mechanism to collect refugees' feedback on the quality, sufficiency, utilization and effectiveness of the assistance items they receive. In order to ensure that the cash assistance provided meets the intended programme objectives and that desired outcomes are achieved, UNHCR conducts regular post-distribution and outcome monitoring with a sample or all of the recipients.

Geographic coverage

The survey covers Eastern Nepal (Pathari sanichare and Beldangi refugee camps) and refugees living in Kathmandu.

Analysis unit

Households

Universe

The sample universe covers all urban refugee households (239) living in Kathmandu as well as all 2,409 Bhutanese refugee households living in Pathari sanichare and Beldangi camps.

Kind of data

Sample survey data [ssd]

Sampling procedure

Stratified random sampling was implemented drawing two samples seperately for urban and Bhutanese (camp) refugees.

Mode of data collection

Mail Questionnaire [mail]

Context

Covid-19 Data of European Countries as on 1 September , 2021

Content

Content

.csv file with columns Country,Total Cases, Total Deaths, Total Recovered, Active Cases, Total Cases per 1M population, Deaths per 1M population, Total Tests, Tests per 1M population, Population

Acknowledgements

Source Link : https://www.worldometers.info/coronavirus/#countries

Project Overview This portion of the COVID DIARIES project provides full bibliographic information (including original and permanent links) to media items related to the COVID-19 vaccination program, published on the official websites of 20 major U.S. news outlets, including television networks, magazines, and newspapers. It spans the period from December 2020, when states began implementing Phase 1a of the vaccine allocation plan, through September 2021, when vaccines became widely available to all adults and were frequently mandated. News items were collected to preserve a contemporaneous record of how the vaccination effort was discussed across national media. The dataset enables researchers to analyze media communication strategies during a nationwide public health emergency, with the broader aim of informing more effective public health messaging through mass media. This project represents a collaborative effort between the Yale School of Medicine and the Tobin Center for Economic Policy. Data and Data Collection Overview This collection comprises 5,383 unique publication links from 20 major news outlets—including television networks, magazines, and newspapers—published between December 1, 2020, and September 30, 2021. Only articles that were freely accessible online without subscription or paywall restrictions were included. Articles were collected by the research team (specifically AM) between August 2021 and November 2023 and in April 2024 (by AM and AG). These 20 news outlets were selected based on a 2020–2021 survey of 511 U.S. adults, which identified the outlets most commonly used to obtain information about the COVID-19 vaccination program. A full list of news outlets, along with their reported usage and perceived trustworthiness, is provided in Sources_Selection.docx. Online publications were identified using Google search with a custom date range in week-long increments (e.g., 12/01/2020–12/07/2020), using the keyword “vaccine” in combination with the link to the respective news outlet’s website. Search results were manually reviewed by AM according to the following inclusion and exclusion criteria. Inclusion criteria: Articles published on the selected U.S. news outlets websites ending in “.com” or “.co” that relate to the COVID-19 vaccination program; Articles from the selected international news outlets that serve both their country of origin and the U.S. audience (e.g., BBC, The Daily Mail). Exclusion criteria: Articles published on the international news outlets websites that exclusively serve their country of origin (e.g., domains ending in .uk, .ca, etc. without .com, .co); Publications from universities, government agencies, or other organizations not affiliated with major U.S. news outlets (e.g., domains ending in .edu, .gov, .org); Videos without accompanying transcripts; Publications without textual content; Articles referencing vaccines unrelated to COVID-19; Non-English language publications. Selection and Organization of Shared Data The full list of publications is provided in the data file named "News_Outlets_Publications_Full_List." Entries are organized by news outlet (one per tab), then by publication year, month, week, and article title within each tab. For each entry, the list includes the article’s original download date by the research team, file format (e.g., PDF), original link to the publication, and a permanent link record. The list was verified by MC, CA, AV, AG, and AM, with final quality control performed by AM. Each article was assigned a unique identifier in the format: "Article Title – News Outlet Name", ensuring that each entry appears only once in the final dataset. Additional documentation includes this Data Narrative, a document explaining the source selection and an administrative README file.

As of September 2021, governments around the world intervened to the economy through various types of governmental aids to support airlines and avoid any major bankruptcy filing in the aviation industry. Until the end of September 2021, aid issued directly to airlines amounted to close to ** billion U.S. dollars in response to the coronavirus(COVID-19) shock.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it. The purpose behind releasing this data is to present regional and local data to allow for its use in public health. It will also allow for greater analysis, modelling and planning to be performed using the latest data, to aid in the response to the pandemic. We will update this weekly and we would welcome your feedback to help us develop our open data sets. The data that is published is based on version 73 of the SPL clinical methodology, with the data extracted as at 15 September 2021.

New Covid tests per month in Brazil, September, 2021 The most recent value is 3787260 new Covid tests as of September 2021, an increase compared to the previous value of 2239698 new Covid tests. Historically, the average for Brazil from April 2020 to September 2021 is 4641320 new Covid tests. The minimum of 436538 new Covid tests was recorded in April 2020, while the maximum of 20400000 new Covid tests was reached in October 2020. | TheGlobalEconomy.com

The file contains Tweet IDs* for COVID-19 related tweets collected in September, 2021 from Twitter's COVID-19 Streaming Endpoint via a custom script developed by the Social Media Lab (https://socialmedialab.ca/). Visit our interactive dashboard at https://stream.covid19misinfo.org/ for a preview and some general stats about this COVID-19 Twitter streaming dataset. For more info about Twitter's COVID-19 Streaming Endpoint, visit https://developer.twitter.com/en/docs/labs/covid19-stream/overviewNote: In accordance with Twitter API Terms, the dataset only includes Tweet IDs (as opposed to the actual tweets and associated metadata). To recollect tweets contained in this dataset, you can use programs such as Hydrator (https://github.com/DocNow/hydrator/) or the Python library Twarc (https://github.com/DocNow/twarc/).

As of September 2021, 27 percent of adults in Russia reported that they were unwilling to get a COVID-19 vaccine, while around 17 percent of adults in the United States stated the same. This statistic illustrates the percentage of adults who were vaccinated against COVID-19, plan to get vaccinated, or unwilling to get vaccinated worldwide as of September 2021, by country.

In March 2021, around 37 percent of adults in the United Stated reported that they were unwilling to get a COVID-19 vaccine. By September 2021, the number had dropped to around 27 percent. This statistic illustrates the percentage of adults who were unwilling to get vaccinated against COVID-19 or were uncertain from March to September 2021 worldwide, by country.

New Covid vaccinations per month in Tajikistan, September, 2021 The most recent value is 3397950 new Covid vaccinations as of September 2021, an increase compared to the previous value of 355880 new Covid vaccinations. Historically, the average for Tajikistan from July 2021 to September 2021 is 1876915 new Covid vaccinations. The minimum of 355880 new Covid vaccinations was recorded in July 2021, while the maximum of 3397950 new Covid vaccinations was reached in September 2021. | TheGlobalEconomy.com

New Covid tests per month in Madagascar, September, 2021 The most recent value is 20790 new Covid tests as of September 2021, an increase compared to the previous value of 13847 new Covid tests. Historically, the average for Madagascar from April 2020 to September 2021 is 16919 new Covid tests. The minimum of 2445 new Covid tests was recorded in April 2020, while the maximum of 40410 new Covid tests was reached in April 2021. | TheGlobalEconomy.com

The file contains Tweet IDs* for COVID-19 related tweets containing at least one vaccine-related word (i.e., words that starts with vaccin*, vacin*, or vax*) collected in September, 2021 from Twitter's COVID-19 Streaming Endpoint via a custom script developed by the Social Media Lab (https://socialmedialab.ca/). Visit our interactive dashboard at https://stream.covid19misinfo.org/ for a preview and some general stats about this COVID-19 Twitter streaming dataset.

For more info about Twitter's COVID-19 Streaming Endpoint, visit https://developer.twitter.com/en/docs/labs/covid19-stream/overview

• Note: In accordance with Twitter API Terms, the dataset only includes Tweet IDs (as opposed to the actual tweets and associated metadata). To recollect tweets contained in this dataset, you can use programs such Communalytic (https://communalytic.com/), Hydrator (https://github.com/DocNow/hydrator/) or the Python library Twarc (https://github.com/DocNow/twarc/).

New Covid vaccinations per month in Iceland, September, 2021 The most recent value is 58341 new Covid vaccinations as of September 2021, an increase compared to the previous value of 55304 new Covid vaccinations. Historically, the average for Iceland from February 2021 to September 2021 is 171357 new Covid vaccinations. The minimum of 31505 new Covid vaccinations was recorded in February 2021, while the maximum of 312761 new Covid vaccinations was reached in June 2021. | TheGlobalEconomy.com

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138

As of November 2021, the French population was rather trustful of the government's ability to successfully perform its vaccination campaign against COVID-19. According to this survey, ** percent of respondents trusted in the government's performance in its vaccine campaign. On the other hand, *** out of five respondents had very little trust.

the Vientiane Mayor thus issues the order on the COVID-19 outbreak prevention, control, and response measures in VTE Capital within the period of 19 -30 Sept 2021.